Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584 Stock Report

Market Cap: CN¥2.3b

Nanjing Hicin Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yuping Cao

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.2yrs
CEO ownership0.4%
Management average tenureno data
Board average tenure5.2yrs

Recent management updates

Recent updates

There's Reason For Concern Over Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) Massive 28% Price Jump

Aug 15
There's Reason For Concern Over Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) Massive 28% Price Jump

We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

May 01
We Think Nanjing Hicin Pharmaceutical's (SZSE:300584) Profit Is Only A Baseline For What They Can Achieve

Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) 29% Price Boost Is Out Of Tune With Revenues

Mar 08
Nanjing Hicin Pharmaceutical Co., Ltd.'s (SZSE:300584) 29% Price Boost Is Out Of Tune With Revenues

CEO

Yuping Cao (60 yo)

8.2yrs

Tenure

CN¥411,500

Compensation

Mr. Yuping Cao serves as Chairman of the Board and General Manager at Nanjing Hicin Pharmaceutical Co., Ltd. He serves as Director at Nanjing Hicin Pharmaceutical Co., Ltd. since July 20, 2016.He complete...


Board Members

NamePositionTenureCompensationOwnership
Yuping Cao
GM & Chairman of the Board8.2yrsCN¥411.50k0.38%
CN¥ 8.7m
Yan Luo
Chairman of the Supervisory Board5.2yrsno data0.0027%
CN¥ 60.9k
Xiang Li
Independent Director5.2yrsCN¥96.00kno data
Mingsheng Feng
Non-Independent Director2.2yrsCN¥190.50kno data
Hao Zhou
Independent Director5.2yrsCN¥96.00kno data
Liye Zhu
Supervisor5.2yrsno datano data
Ming Zhao
Independent Director5.2yrsCN¥96.00kno data
Xichen Cao
Non-Independent Director2.2yrsCN¥100.60kno data
Qiong Wang
Supervisorno datano datano data
Yuanhong Chu
Supervisor2.2yrsno datano data

5.2yrs

Average Tenure

44yo

Average Age

Experienced Board: 300584's board of directors are considered experienced (5.2 years average tenure).